Latest News & Features
Americas
The US Supreme Court has refused to hear the Organic Seed Growers and Trade Association’s case against Monsanto, along with two other patent cases as revealed in a document released on January 13. 14 January 2014
Big Pharma
Three December decisions from the Court Of Justice of the European Union shed light on supplementary protection certificates in Europe. 13 January 2014
Americas
Stem cells are seen by many as the great hope for medical research in the years to come. LSIPR spoke to Nicholas Seay, chief technology officer at Cellular Dynamics, about the importance of IP in this field. 13 January 2014
Americas
General Electric has bought three life sciences divisions from US company Thermo Fisher Scientific in a deal worth about $1.06 billion. 13 January 2014
Americas
Biopharmaceutical company Alnylam has paid Merck $175 million for its subsidiary Sirna Therapeutics, a firm specialising in RNA interference therapeutics. 13 January 2014
Americas
Edwards Wildman Palmer LLP has hired Edward Glynn, a former senior official at the Federal Trade Commission. 9 January 2014
Americas
Anishiya Abrol, a life sciences IP specialist, has been promoted to counsel at law firm Hogan Lovells. 8 January 2014
Americas
Enzo Biochem, a US biotechnology company, has received another $12.4 million from a patent ruling against Applera Corp, bringing the total damages sum to around $61 million. 7 January 2014
Big Pharma
EIP has hired IP litigator Matthew Jones from Teva Pharmaceuticals Europe as a partner. 7 January 2014
Americas
IP litigator Thomas Wintner has been appointed partner at Edwards Wildman Palmer LLP. 6 January 2014